These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1511061)

  • 1. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus.
    Sitter T; Spannagl M; Schiffl H
    Ann Hematol; 1992 Aug; 65(2):79-82. PubMed ID: 1511061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease.
    García-Martín F; De Arriba G; Carrascosa T; Moldenhauer F; Martin-Escobar E; Val J; Saiz F
    Nephrol Dial Transplant; 1991; 6(8):543-7. PubMed ID: 1956552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticardiolipin antibodies in patients with venous thrombosis.
    Kapiotis S; Speiser W; Pabinger-Fasching I; Kyrle PA; Lechner K
    Haemostasis; 1991; 21(1):19-24. PubMed ID: 1907589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticardiolipin antibodies in cutaneous lupus erythematosus. Incidence and importance as a marker of vascular symptoms].
    Tebbe B; Orfanos CE
    Hautarzt; 1992 Mar; 43(3):130-3. PubMed ID: 1577600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and clinical significance of lupus anticoagulant and anticardiolipin antibody in 349 patients with systemic lupus erythematosus.
    Ninomiya C; Taniguchi O; Kato T; Hirano T; Hashimoto H; Hirose S
    Intern Med; 1992 Feb; 31(2):194-9. PubMed ID: 1600266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
    Wong KL; Liu HW; Ho K; Chan K; Wong R
    J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
    McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
    Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.
    Out HJ; van Vliet M; de Groot PG; Derksen RH
    Ann Rheum Dis; 1992 Mar; 51(3):353-7. PubMed ID: 1575581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population.
    Shi W; Krilis SA; Chong BH; Gordon S; Chesterman CN
    Aust N Z J Med; 1990 Jun; 20(3):231-6. PubMed ID: 2115326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
    Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
    Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.
    Cervera R; Font J; López-Soto A; Casals F; Pallarés L; Bové A; Ingelmo M; Urbano-Márquez A
    Ann Rheum Dis; 1990 Feb; 49(2):109-13. PubMed ID: 2107799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus.
    Tincani A; Meroni PL; Brucato A; Zanussi C; Allegri F; Mantelli P; Cattaneo R; Balestrieri G
    Clin Exp Rheumatol; 1985; 3(4):321-6. PubMed ID: 4085163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of lupus anticoagulant and anticardiolipin antibodies in haemodialysis patients.
    Phillips AO; Jones HW; Hambley H; Hillis AN; Hendry BM
    Nephron; 1993; 65(3):350-3. PubMed ID: 8289982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin antibodies in acquired immunodeficiency syndrome.
    Stimmler MM; Quismorio FP; McGehee WG; Boylen T; Sharma OP
    Arch Intern Med; 1989 Aug; 149(8):1833-5. PubMed ID: 2504122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus.
    Frijns CJ; Derksen RH; De Groot PG; Algra A; Fijnheer R
    Clin Exp Immunol; 2001 Jul; 125(1):149-54. PubMed ID: 11472438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.